Aemetis, Inc (NASDAQ:AMTX) Director Sells $66,923.56 in Stock

Aemetis, Inc (NASDAQ:AMTX) Director Francis P. Barton sold 26,452 shares of Aemetis stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $2.53, for a total value of $66,923.56. Following the completion of the sale, the director owned 208,518 shares of the company’s stock, valued at $527,550.54. The trade was a 11.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Aemetis Stock Performance

Shares of Aemetis stock opened at $2.49 on Friday. The company has a market capitalization of $157.47 million, a PE ratio of -1.54 and a beta of 1.49. The company has a 50-day simple moving average of $2.66 and a two-hundred day simple moving average of $2.05. Aemetis, Inc has a one year low of $1.22 and a one year high of $4.73.

Aemetis (NASDAQ:AMTX) last announced its earnings results on Thursday, August 7th. The specialty chemicals company reported ($0.41) EPS for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.06). The business had revenue of $52.24 million for the quarter, compared to analyst estimates of $78.68 million. On average, equities analysts predict that Aemetis, Inc will post -2.07 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Aemetis

A number of large investors have recently added to or reduced their stakes in AMTX. Catalyst Funds Management Pty Ltd bought a new position in Aemetis in the second quarter worth about $25,000. ProShare Advisors LLC acquired a new position in shares of Aemetis during the fourth quarter valued at about $27,000. Voya Investment Management LLC acquired a new position in shares of Aemetis during the fourth quarter valued at about $28,000. Tower Research Capital LLC TRC increased its holdings in shares of Aemetis by 128.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,407 shares of the specialty chemicals company’s stock valued at $28,000 after acquiring an additional 5,859 shares in the last quarter. Finally, R Squared Ltd acquired a new position in shares of Aemetis during the second quarter valued at about $30,000. 27.02% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms recently weighed in on AMTX. UBS Group lifted their price objective on Aemetis from $2.20 to $3.00 and gave the company a “buy” rating in a report on Monday, June 30th. Ascendiant Capital Markets lifted their price objective on Aemetis from $19.00 to $20.00 and gave the company a “buy” rating in a report on Friday, June 6th.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.